In April 2018, the Pistoia Alliance hosted a workshop at the Royal Society of Chemistry in London on the topic of “NGS, CDx and Regulation”.
The objective of the workshop was to identify opportunities better to align CDx data standards and working practices in the research domain and the clinical domain thereby speeding the development, certification and deployment of safe and effective CDx to support precision medicine.
Speakers from GSK research, MHRA, BSI (a Notified Body), EMQN and Almac Diagnostic Services presented their different perspectives of the opportunities and challenges facing the use of NGS in CDx.
One of the key outcomes of the workshop was the realization that there were several specialist areas which were not as well understood by the practitioners (e.g., regulators, notified bodies, management in biopharma, clinicians and other specialists in related areas) as was desirable. As such, the workshop delegates suggested it would be helpful to create a forum where a basic level of understanding of these different NGS technologies could be considered along with presentations of different use cases demonstrating their different applicabilities.
Three key educational themes were identified:
- NGS Technologies
- Clinical Bioinformatics
In the first of these themes The Pistoia Alliance is addressing is NGS Technologies. This symposium will bring together the key actors who will provide a basic understanding of their technologies and examples of their potential application in the life science R&D and healthcare continuum. Register now